Genesem Statistics

Total Valuation

Genesem has a market cap or net worth of KRW 59.54 billion. The enterprise value is 67.71 billion.

Market Cap	59.54B
Enterprise Value	67.71B

Important Dates

The next estimated earnings date is Friday, February 14, 2025.

Earnings Date	Feb 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Genesem has 8.77 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	8.77M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	44.36%
Owned by Institutions (%)	0.58%
Float	4.88M

Valuation Ratios

The trailing PE ratio is 8.73.

PE Ratio	8.73
Forward PE	n/a
PS Ratio	0.85
PB Ratio	1.28
P/TBV Ratio	1.33
P/FCF Ratio	17.48
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.55, with an EV/FCF ratio of 19.88.

EV / Earnings	9.92
EV / Sales	0.96
EV / EBITDA	7.55
EV / EBIT	8.81
EV / FCF	19.88

Financial Position

The company has a current ratio of 1.39, with a Debt / Equity ratio of 0.45.

Current Ratio	1.39
Quick Ratio	0.80
Debt / Equity	0.45
Debt / EBITDA	2.32
Debt / FCF	6.10
Interest Coverage	8.66

Financial Efficiency

Return on equity (ROE) is 16.17% and return on invested capital (ROIC) is 7.47%.

Return on Equity (ROE)	16.17%
Return on Assets (ROA)	5.99%
Return on Capital (ROIC)	7.47%
Revenue Per Employee	464.77M
Profits Per Employee	45.18M
Employee Count	151
Asset Turnover	0.88
Inventory Turnover	2.62

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.92% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-47.92%
50-Day Moving Average	7,817.20
200-Day Moving Average	10,487.45
Relative Strength Index (RSI)	41.52
Average Volume (20 Days)	34,852

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genesem had revenue of KRW 70.18 billion and earned 6.82 billion in profits. Earnings per share was 778.02.

Revenue	70.18B
Gross Profit	30.15B
Operating Income	7.68B
Pretax Income	6.92B
Net Income	6.82B
EBITDA	8.97B
EBIT	7.68B
Earnings Per Share (EPS)	778.02

Full Income Statement

Balance Sheet

The company has 12.51 billion in cash and 20.79 billion in debt, giving a net cash position of -8.27 billion or -943.62 per share.

Cash & Cash Equivalents	12.51B
Total Debt	20.79B
Net Cash	-8.27B
Net Cash Per Share	-943.62
Equity (Book Value)	46.47B
Book Value Per Share	5,311.57
Working Capital	12.01B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.62 billion and capital expenditures -1.21 billion, giving a free cash flow of 3.41 billion.

Operating Cash Flow	4.62B
Capital Expenditures	-1.21B
Free Cash Flow	3.41B
FCF Per Share	388.35

Full Cash Flow Statement

Margins

Gross margin is 42.96%, with operating and profit margins of 10.95% and 9.72%.

Gross Margin	42.96%
Operating Margin	10.95%
Pretax Margin	9.86%
Profit Margin	9.72%
EBITDA Margin	12.78%
EBIT Margin	10.95%
FCF Margin	4.85%

Dividends & Yields

Genesem does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	11.46%
FCF Yield	5.72%

Dividend Details

Stock Splits

The last stock split was on November 10, 2015. It was a forward split with a ratio of 2.

Last Split Date	Nov 10, 2015
Split Type	Forward
Split Ratio	2

Scores

Genesem has an Altman Z-Score of 3.31.

Altman Z-Score	3.31
Piotroski F-Score	n/a